Clinical trial • Not applicable • Other

rocuronium for Postoperative residual neuromuscular blockade

Not applicable trial of rocuronium for Postoperative residual neuromuscular blockade.

Overview

Trial Therapeutic Area
Other
Trial Disease
Postoperative residual neuromuscular blockade
Trial Stage
Not applicable
Drug Modality
Small molecule

Key dates

Initial CTIS Submission Date
12-04-2024
First CTIS Authorization Date
12-06-2024

Trial design

Randomised, placebo (placebo-controlled arm); dose and schedule not specified Not applicable trial across 1 site in Hungary.

Randomised
Yes
Comparator
Placebo (placebo-controlled arm); dose and schedule not specified
Target Sample Size
75

Recruitment

Planned Sample Size
75
Recruitment Window Months
49

Geography

Total Number Of Sites
1
Total Number Of Participants
75

Hungary

Earliest CTIS Part Ii Submission Date
31-05-2024
Latest Decision Or Authorization Date
12-06-2024
Processing Time Days
12
Number Of Sites
1
Number Of Participants
75

Sites

Site Name
University Of Debrecen
Department Name
FACULTY OF MEDICINE Department of Anesthesiology and Intensive Care
Principal Investigator Name
Tamás Végh
Principal Investigator Email
veghdr@med.unideb.hu
Contact Person Name
Tamás Végh
Contact Person Email
veghdr@med.unideb.hu
Number Of Participants
75

Sponsor

Primary sponsor

Full Name
University Of Debrecen
Organisation Type
Educational Institution
Country Of Registered Address
Hungary

Investigational products

Investigational Product Name
rocuronium
Active Substance
rocuronium
Modality
Small molecule

Related trials

Other published trials that may interest you.